## **Core Concept**
The question revolves around the management of angina pectoris using transdermal nitroglycerin patches and the phenomenon of nitrate tolerance, which occurs with continuous use of nitrates.

## **Why the Correct Answer is Right**
The correct answer, , is related to the development of **nitrate tolerance**. When nitroglycerin is administered continuously via transdermal patches, the body adapts by changing the way it responds to the medication. This adaptation involves complex biochemical pathways, including alterations in **cyclic guanosine monophosphate (cGMP)** signaling and increased production of **reactive oxygen species (ROS)**, which counteract the vasodilatory effects of nitroglycerin. As a result, patients may experience a return of angina symptoms, as seen in this case. The fact that the patient applies a new patch every morning immediately after removing the old one ensures a continuous presence of nitroglycerin, which is a common strategy leading to tolerance.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because simply removing the patch overnight (**patch removal**) does not fully address the issue of tolerance in this scenario; the question implies continuous use.
- **Option B:** This option is incorrect as there is no mention or implication of **increased myocardial oxygen demand** directly related to the use of nitroglycerin patches.
- **Option C:** This option is incorrect because **decreased nitrate absorption** would not lead to an increased frequency of anginal attacks; if anything, it would decrease the effectiveness but not in the context provided.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that to avoid nitrate tolerance, a **nitrate-free interval** of 8-12 hours per day is recommended when using long-acting nitrate preparations like transdermal nitroglycerin patches. This strategy can help maintain the efficacy of nitrates in managing angina.

## **Correct Answer: D.**